Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Bolt Biotherapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +6 vs. Q3 2023
- Shares held
- 24.1M
- −1.34K (0.0%) vs. Q3 2023
- Total value
- $27.0M
- +$1.93M (+7.7%) vs. Q3 2023
- New holders
- 7
- 9 more added
- Sold out
- 1
- 12 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BOLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $2.31M |
| Q1 2026 | 24 | $2.49M |
| Q4 2025 | 21 | $3.30M |
| Q3 2025 | 24 | $4.28M |
| Q2 2025 | 25 | $5.10M |
| Q1 2025 | 30 | $7.33M |
| Q4 2024 | 38 | $9.99M |
| Q3 2024 | 32 | $12.2M |
| Q2 2024 | 37 | $17.0M |
| Q1 2024 | 39 | $33.6M |
| Q4 2023 | 40 | $27.0M |
| Q3 2023 | 35 | $25.5M |
| Q2 2023 | 40 | $32.1M |
| Q1 2023 | 41 | $32.4M |
| Q4 2022 | 44 | $26.8M |
| Q3 2022 | 56 | $39.7M |
| Q2 2022 | 62 | $54.8M |
| Q1 2022 | 66 | $79.3M |
| Q4 2021 | 62 | $164.6M |
| Q3 2021 | 72 | $449.1M |
| Q2 2021 | 61 | $513.8M |
| Q1 2021 | 70 | $1.04B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Bolt Biotherapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 3,652,244 | $4.09M | 0.38% | +95,204+2.7% | Added |
| Vivo Capital, LLC | 3,521,291 | $3.94M | 0.32% | −350,000−9.0% | Reduced |
| Sofinnova Investments, Inc. | 2,754,437 | $3.08M | 0.17% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,458,958 | $2.75M | 0.00% | −394,676−13.8% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $2.12M | 0.54% | 00.0% | Unchanged |
| Newtyn Management, LLC | 1,553,535 | $1.74M | 0.34% | +533,535+52.3% | Added |
| OrbiMed Advisors LLC | 1,541,000 | $1.73M | 0.03% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 1,166,952 | $1.31M | 0.81% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,049,153 | $1.18M | 0.18% | 00.0% | Unchanged |
| Vanguard Group Inc | 931,129 | $1.04M | 0.00% | +6,864+0.7% | Added |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $805.9K | 0.05% | −37,551−5.0% | Reduced |
| Adage Capital Partners GP, L.L.C. | 500,000 | $560.0K | 0.00% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 459,455 | $514.6K | 0.27% | −924−0.2% | Reduced |
| Renaissance Technologies LLC | 445,273 | $499.0K | 0.00% | +131,084+41.7% | Added |
| Geode Capital Management, LLC | 350,164 | $392.3K | 0.00% | −10,575−2.9% | Reduced |
| BlackRock Inc. | 257,271 | $288.1K | 0.00% | −752−0.3% | Reduced |
| Privium Fund Management (UK) Ltd | 116,516 | $130.5K | 0.09% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 111,200 | $124.5K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 96,673 | $108.3K | 0.02% | −1,162−1.2% | Reduced |
| Squarepoint Ops LLC | 79,772 | $89.3K | 0.00% | −265−0.3% | Reduced |
| Morgan Stanley | 79,394 | $88.9K | 0.00% | −80,374−50.3% | Reduced |
| FMR LLC | 79,193 | $88.7K | 0.00% | −30.0% | Reduced |
| Two Sigma Securities, LLC | 64,232 | $71.9K | 0.00% | +64,232 | New |
| Jane Street Group, LLC | 56,264 | $63.0K | 0.00% | +56,264 | New |
| State Street Corp | 47,437 | $53.1K | 0.00% | −1,300−2.7% | Reduced |
| Millennium Management LLC | 47,007 | $52.6K | 0.00% | +2,024+4.5% | Added |
| Northern Trust Corp | 41,005 | $45.9K | 0.00% | +9,823+31.5% | Added |
| XTX Topco Ltd | 19,152 | $21.4K | 0.00% | +19,152 | New |
| Prudential Financial Inc | 12,200 | $13.7K | 0.00% | +12,200 | New |
| Tower Research Capital LLC (TRC) | 8,236 | $9.22K | 0.00% | +8,236 | New |
| UBS Group AG | 7,651 | $8.57K | 0.00% | +7,565+8,796.5% | Added |
| Advisor Group Holdings, Inc. | 3,978 | $4.46K | 0.00% | +3,978 | New |
| Citigroup Inc | 2,307 | $2.58K | 0.00% | +2,307 | New |
| JPMorgan Chase & Co | 840 | $941 | 0.00% | −75,447−98.9% | Reduced |
| Bank of America Corp | 628 | $703 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 207 | $232 | 0.00% | +10+5.1% | Added |
| Barclays PLC | 139 | $156 | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 40 | $45 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 465 | $0 | 0.00% | +371+394.7% | Added |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1,161−100.0% | Sold out |
| Hawkeye Capital Management, LLC | – | – | – | – | Not filed |